Clinical utility of squamous and transitional nuclear structure alterations induced by Schistosoma haematobium in chronically infected adults with bladder damage verified by ultrasound in Ghana

Analytical and Quantitative Cytology and Histology

Volumn 31, Issue 3, 2009, Pages 143-152

  Naples, Jean ^d   Isharwal, Sumit ^d   Shiff, Clive J ^a   Bosompem, Kwabena M ^b   Veltri, Robert W ^c  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b University of Ghana   (Ghana)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NONE

Author keywords

Bladder diseases; Quantitative nuclear morphometry; Schistosoma haematobium; Squamous cells; Transitional cells

Indexed keywords

DNA;

ADULT; AREA UNDER THE CURVE; ARTICLE; BLADDER INJURY; CELL STRUCTURE; CHROMATIN STRUCTURE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIGITAL IMAGING; DNA CONTENT; ECHOGRAPHY; ENDEMIC DISEASE; GHANA; HUMAN; HUMAN CELL; HUMAN TISSUE; MORPHOMETRICS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RECEIVER OPERATING CHARACTERISTIC; SCHISTOSOMA HEMATOBIUM; SCHISTOSOMIASIS HAEMATOBIA; SQUAMOUS CELL; URINE SEDIMENT; UROTHELIUM; VALIDATION STUDY;

ADULT; ANIMALS; CELL NUCLEUS; CHRONIC DISEASE; GHANA; HUMANS; LOGISTIC MODELS; SCHISTOSOMA HAEMATOBIUM; SCHISTOSOMIASIS HAEMATOBIA; URINARY BLADDER DISEASES; UROTHELIUM;

SCHISTOSOMA HAEMATOBIUM;

EID: 67849116600     PISSN: 08846812     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Parkin DM: The global health burden of infection-associated cancers in the year 2002. Int J Cancer 2006;118:3030-3044
2. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ: Cancer statistics, 2008. CA Cancer J Clin 2008;58:71-96
3. Heyns CF, van der Merwe A: Bladder cancer in Africa. Can J Urol 2008;15:3899-3908
4. Gryseels B, Polman K, Clerinx J, Kestens L: Human schistosomiasis. Lancet 2006;368:1106-1118
5. Badawi AF, Mostafa MH, Probert A, O'Connor PJ: Role of schistosomiasis in human bladder cancer: Evidence of association, aetiological factors, and basic mechanisms of carcinogenesis. Eur J Cancer Prev 1995;4:45-59
6. Yosry A: Schistosomiasis and neoplasia. Contrib Microbiol 2006;13:81-100
7. Hodder SL, Mahmoud AA, Sorenson K, Weinert DM, Stein RL, Ouma JH, Koech D, King CH: Predisposition to urinary tract epithelial metaplasia in Schistosoma haematobium infection. Am J Trop Med Hyg 2000;63:133-138 (Pubitemid 32488349)
8. Brouwer KC, Ndhlovu PD, Wagatsuma Y, Munatsi A, Shiff CJ: Epidemiological assessment of Schistosoma haematobiuminduced kidney and bladder pathology in rural Zimbabwe. Acta Trop 2003;85:339-347 (Pubitemid 36349559)
9. Shiff C, Veltri R, Naples J, Quartey J, Otchere J, Anyan W, Marlow C, Wiredu E, Adjei A, Brakohiapa E, Bosompem K: Ultrasound verification of bladder damage is associated with known biomarkers of bladder cancer in adults chronically infected with Schistosoma haematobium in Ghana. Trans R Soc Trop Med Hyg 2006;100:847-854 (Pubitemid 43986282)
10. King CH, Dickman K, Tisch DJ: Reassessment of the cost of chronic helmintic infection: A meta-analysis of disabilityrelated outcomes in endemic schistosomiasis. Lancet 2005; 365:1561-1569 (Pubitemid 40615405)
11. Gill JE, Jotz MM: Further observations on the chemistry of pararosaniline-Feulgen staining. Histochemistry 1976;46: 147-160
12. Schulte E, Wittekind D: Standardization of the Feulgen- Schiff technique: Staining characteristics of pure fuchsin dyes: A cytophotometric investigation. Histochemistry 1989; 91:321-331 (Pubitemid 19122878)
13. Veltri RW, Partin AW, Miller MC: Quantitative nuclear grade (QNG): A new image analysis-based biomarker of clinically relevant nuclear structure alterations. J Cell Biochem (suppl) 2000;35:151-157
14. Veltri RW, Khan MA, Miller MC, Epstein JI, Mangold LA, Walsh PC, Partin AW: Ability to predict metastasis based on pathology findings and alterations in nuclear structure of normal-appearing and cancer peripheral zone epithelium in the prostate. Clin Cancer Res 2004;10:3465-3473
15. Veltri RW, Partin AW, Miller CM: Quantitative Nuclear Grade (QNG): The clinical applications of the quantitative measurement of nuclear structure using image analysis. In Cancer Chemoprevention. Edited by GJ Kelloff, ET Hawk, CC Sigman. Totowa, New Jersey, Humana Press, 2005, pp 97-108
16. Veltri RW, Marlow C, Khan MA, Miller MC, Epstein JI, Partin AW: Significant variations in nuclear structure occur between and within Gleason grading patterns 3, 4, and 5 determined by digital image analysis. Prostate 2007;67:1202-1210
17. Veltri RW, Miller MC, Isharwal S, Marlow C, Makarov DV, Partin AW: Prediction of prostate-specific antigen recurrence in men with long-term follow-up postprostatectomy using quantitative nuclear morphometry. Cancer Epidemiol Biomarkers Prev 2008;17:102-110 (Pubitemid 351196279)
18. Sauerbrei W: The use of resampling methods to simplify regression models in medical statistics. Applied Stat 1999;48:313-329
19. Mostafa MH, Sheweita SA, O'Connor PJ: Relationship between schistosomiasis and bladder cancer. Clin Microbiol Rev 1999;12:97-111
20. Lamm DL, Torti FM: Bladder cancer, 1996. CA Cancer J Clin 1996;46:93-112
21. Farrow GM: Urine cytology in the detection of bladder cancer: A critical approach. J Occup Med 1990;32:817-821
22. Carducci MA, Piantadosi S, Pound CR, Epstein JI, Simons JW, Marshall FF, Partin AW: Nuclear morphometry adds significant prognostic information to stage and grade for renal cell carcinoma. Urology 1999;53:44-49 (Pubitemid 29016612)
23. Kapur U, Antic T, Venkataraman G, Durazo-Arvizu R, Quek MM, Flanigan RC, Wojcik EM: Validation of World Health Organization/International Society of Urologic Pathology 2004 classification schema for bladder urothelial carcinomas using quantitative nuclear morphometry: Identification of predictive features using bootstrap method. Urology 2007; 70:1028-1033
24. Ramos D, Ruiz A, Morell L, Navarro S, Villamon R, Gil- Salom M, Llombart-Bosch A: Prognostic value of morphometry in low grade papillary urothelial bladder neoplasms. Analyt Quant Cytol Histol 2004;26:285-294 (Pubitemid 39458648)
25. Bol MG, Baak JP, Rep S, Marx WL, Kruse AJ, Bos SD, Kisman O, Voorhorst FJ: Prognostic value of proliferative activity and nuclear morphometry for progression in TaT1 urothelial cell carcinomas of the urinary bladder. Urology 2002;60: 1124-1130 (Pubitemid 35447592)
26. Lipponen PK, Collan Y, Eskelinen MJ, Pesonen E, Sotarauta M: Morphometry in human transitional cell bladder cancer: Nuclear area and standard deviation of nuclear area: Relation to tumor grade (WHO) and prognosis. Eur Urol 1990; 17:155-160 (Pubitemid 20082444)
27. Fukuzawa S, Hashimura T, Sasaki M, Yamabe H, Yoshida O: Nuclear morphometry for improved prediction of the prognosis of human bladder carcinoma. Cancer 1995;76:1790-1796
28. van Velthoven R, Petein M, Oosterlinck W, De Wilde T, Mattelaer J, Hardeman M, Kiss R, Decaestecker C: Identification by quantitative chromatin pattern analysis of patients at risk for recurrence of superficial transitional bladder carcinoma. J Urol 2000;164:2134-2137 (Pubitemid 30835484)
29. Wojcik EM, Miller MC, O'Dowd GJ, Veltri RW: Value of computer-assisted quantitative nuclear grading in differenti- ation of normal urothelial cells from low and high grade transitional cell carcinoma. Anal Quant Cytol Histol 1998;20: 69-76
30. Salim EI, Morimura K, Menesi A, El-Lity M, Fukushima S, Wanibuchi H: Elevated oxidative stress and DNA damage and repair levels in urinary bladder carcinomas associated with schistosomiasis. Int J Cancer 2008;123:601-608 (Pubitemid 351898418)
31. Eissa S, Ali-Labib R, Khalifa A: Deletion of p16 and p15 genes in schistosomiasis-associated bladder cancer (SABC). Clin Chim Acta 2000;300:159-169 (Pubitemid 30665783)
32. Eissa S, Swelam M, Shaker Y, Abdel-Fattah M, Khalifa A: Expression of p21WAF1/CIP1 in bladder cancer: Relation to schistosomiasis. IUBMB Life 1999;48:115-119 (Pubitemid 29512994)
33. Gutierrez MI, Siraj AK, Khaled H, Koon N, El-Rifai W, Bhatia K: CpG island methylation in Schistosoma- and non- Schistosoma-associated bladder cancer. Mod Pathol 2004;17: 1268-1274 (Pubitemid 39312953)
34. El-Rifai W, Kamel D, Larramendy ML, Shoman S, Gad Y, Baithun S, El-Awady M, Eissa S, Khaled H, Soloneski S, Sheaff M, Knuutila S: DNA copy number changes in Schistosomaassociated and non-Schistosoma-associated bladder cancer. Am J Pathol 2000;156:871-878 (Pubitemid 30626946)
35. Rosin MP, Anwar WA, Ward AJ: Inflammation, chromosomal instability, and cancer: The schistosomiasis model. Cancer Res 1994;54:1929s-1933s
36. Rosin MP, Saad el Din Zaki S, Ward AJ, Anwar WA: Involvement of inflammatory reactions and elevated cell proliferation in the development of bladder cancer in schistosomiasis patients. Mutat Res 1994;305:283-292
37. Rosin MP, Anwar W: Chromosomal damage in urothelial cells from Egyptians with chronic Schistosoma haematobium infections. Int J Cancer 1992;50:539-543
38. Debes JD, Sebo TJ, Heemers HV, Kipp BR, Haugen DL, Lohse CM, Tindall DJ: p300 Modulates nuclear morphology in prostate cancer. Cancer Res 2005;65:708-712
39. Isharwal S, Miller C, Marlow C, Makarov DV, Partin AW, Veltri RW: p300 (Histone Acetyltransferase) biomarker predicts prostate cancer biochemical recurrence and correlates with changes in epithelia nuclear size and shape. Prostate 2008;68:1097-1104